Current clinical applications of in vivo gene therapy with AAVs

JR Mendell, SA Al-Zaidy, LR Rodino-Klapac… - Molecular Therapy, 2021 - cell.com
Hereditary diseases are caused by mutations in genes, and more than 7,000 rare diseases
affect over 30 million Americans. For more than 30 years, hundreds of researchers have …

The genetic basis of phenotypic heterogeneity in the neuronal ceroid lipofuscinoses

E Gardner, SE Mole - Frontiers in Neurology, 2021 - frontiersin.org
The neuronal ceroid lipofuscinoses (NCLs) are a group of inherited neurodegenerative
disorders that affect children and adults. They share some similar clinical features and the …

CLN3 is required for the clearance of glycerophosphodiesters from lysosomes

NN Laqtom, W Dong, UN Medoh, AL Cangelosi… - Nature, 2022 - nature.com
Lysosomes have many roles, including degrading macromolecules and signalling to the
nucleus. Lysosomal dysfunction occurs in various human conditions, such as common …

Impairment of lysosome function and autophagy in rare neurodegenerative diseases

F Darios, G Stevanin - Journal of molecular biology, 2020 - Elsevier
Rare genetic diseases affect a limited number of patients, but their etiology is often known,
facilitating the development of reliable animal models and giving the opportunity to …

Altered protein secretion in Batten disease

RJ Huber - Disease Models & Mechanisms, 2021 - journals.biologists.com
The neuronal ceroid lipofuscinoses (NCLs), collectively known as Batten disease, are a
group of neurological diseases that affect all ages and ethnicities worldwide. There are 13 …

[HTML][HTML] Heterozygous GBA D409V and ATP13a2 mutations do not exacerbate pathological α-synuclein spread in the prodromal preformed fibrils model in young …

ME Johnson, L Bergkvist, L Stetzik, JA Steiner… - Neurobiology of …, 2021 - Elsevier
Autophagic dysregulation and lysosomal impairment have been implicated in the
pathogenesis of Parkinson's disease, partly due to the identification of mutations in multiple …

Neuronal progenitor cells-based metabolomics study reveals dysregulated lipid metabolism and identifies putative biomarkers for CLN6 disease

CM Rus, DL Polla, S Di Bucchianico, S Fischer… - Scientific Reports, 2023 - nature.com
Abstract Neuronal ceroid lipofuscinosis 6 (CLN6) is a rare and fatal autosomal recessive
disease primarily affecting the nervous system in children. It is caused by a pathogenic …

CLN5 and CLN3 function as a complex to regulate endolysosome function

S Yasa, E Sauvageau, G Modica… - Biochemical …, 2021 - portlandpress.com
CLN5 is a soluble endolysosomal protein whose function is poorly understood. Mutations in
this protein cause a rare neurodegenerative disease, neuronal ceroid lipofuscinosis (NCL) …

Converging roles of PSENEN/PEN2 and CLN3 in the autophagy-lysosome system

M Klein, A Kaleem, S Oetjen, D Wünkhaus, L Binkle… - Autophagy, 2022 - Taylor & Francis
ABSTRACT PSENEN/PEN2 is the smallest subunit of the γ-secretase complex, an
intramembrane protease that cleaves proteins within their transmembrane domains …

Recent insights into the networking of CLN genes and proteins in mammalian cells

RJ Huber - Journal of Neurochemistry, 2023 - Wiley Online Library
Ceroid lipofuscinosis neuronal (CLN) genes encode 13 proteins that localize throughout the
endomembrane system to regulate a variety of cellular processes. In humans, mutations in …